This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Gram-Negative Bacterial Infections
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to evaluate the PK/PD parameters, safety and efficacy of extended infusion of beta-lactams in intensive care patients who are infected with Gram-negative bacteremia or pneumonia at National Taiwan University Hospital (NTUH).

Provided treatments

  • Drug: Beta-Lactams
  • Drug: Beta-Lactams
Tris trial is registered with FDA with number: NCT01600768. The sponsor of the trial is National Taiwan University Hospital and it is looking for 100 volunteers for the current phase.
Official trial title: